Hypotension Associated With Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity.


Intravitreal bevacizumab therapy in preterm infants for retinopathy of prematurity (ROP) can be associated with hypotension. We report twin preterm infants who developed hypotension within 1 day after intravitreal bevacizumab therapy for ROP. Before receiving the medication, their clinical statuses were stable and similar. The dose, procedure, and… (More)
DOI: 10.1542/peds.2015-2005


3 Figures and Tables

Slides referencing similar topics